Stereoselective P±O to P±C Rearrangement
1061±1067
129.5 (s, 2C), 150.2 (d, J 7.5 Hz); C12H18NO3P (255.25): calcd. C 56.5, H
J 4.4 Hz, 2C), 125.5 (s), 129.8 (s, 2C), 169.7 (s); C13H17O6P (300.24): calcd.
7.1, N 5.5, P 12.1; found C 57.1, H 7.1, N 5.4, P 12.5.
C 52.0, H 5.7, P 10.5; found C 52.6, H 5.8, P 10.1.
2d: Pale yellow syrup, yield: 20%; [a]D25
65.5 (c 1.1, CH2Cl2); 31P
(R,R)-1,1'-Binaphthalene-2,2'-diylphenylphosphate (2l): Purification by
column chromatography (silica gel; ethyl acetate/petroleum ether 20:80)
1
NMR (40.5 MHz, CDCl3): d 18.7; H NMR (200 MHz, CDCl3): d 0.63
(d, J 6.9 Hz, 3H), 0.80 (d, J 7.0 Hz, 3H), 1.83 (m, 1H), 2.72 (d, J
10.4 Hz, 3H), 3.35 (m, 1H), 3.80 (m, 1H), 4.22 (m, 1H), 7.14 (m, 3H), 7.34
(m, 2H); 13C NMR (50 MHz, CDCl3): d 14.5 (s), 17.4 (s), 28.1 (d, J
6.2 Hz), 30.5 (d, J 5.5 Hz), 63.4 (d, J 13.8 Hz), 65.4 (s), 120.7 (d, J
4.2 Hz, 2C), 124.8 (s), 129.4 (s, 2C), 150.8 (d, J 8.3 Hz); C12H18NO3P
(255.25): calcd. C 56.5, H 7.1, N 5.5, P 12.1; found C 57.3, H 7.2, N 5.6, P 11.9.
afforded 2l as a white solid in 90% yield. [a]D25
276.0 (c 0.5, CH2Cl2);
31P NMR (40.5 MHz, CDCl3): d 4.3; H NMR (200 MHz, CDCl3): d
7.40 (m, 12H), 7.71 (d, J 8.9 Hz, 1H), 8.04 (m, 4H); 13C NMR (50 MHz,
CDCl3): d 117.8 (s), 119.9 (s), 120.0 (s), 120.1 (s), 120.6 (d, J 2.7 Hz),
121.2 (s), 121.6 (s), 123.8 (s), 124.3 (s), 125.6 (s), 125.9 (s, 2C), 126.9 (s, 2C),
127.0 (s), 127.2 (s), 128.6 (d, J 4.0 Hz), 129.9 (s, 2C), 131.2 (s), 131.7 (s),
132.0 (s), 132.3 (s), 146.0 (d, J 10.2 Hz), 147.3 (d, J 12.4 Hz), 150.3 (d,
J 7.9 Hz); C26H17O4P (424.39): calcd. C 73.6, H 4, P 7.3; found: C 73.4, H
4.2, P 7.2.
1
(2S,5S)-2-Phenoxy-3-phenyl-1,3-diaza-2-phosphabicyclo[3.3.0]octane 2-
oxide (2e) and (2R,5S)-2-phenoxy-3-phenyl-1,3-diaza-2-phosphabicy-
clo[3.3.0]octane 2-oxide (2 f): Purification by column chromatography
(silica gel; ethyl acetate/petroleum ether 80:20) afforded an equimolar,
inseparable mixture of the two diastereomers 2e and 2 f as a white solid in
91% yield. 31P NMR (40.5 MHz, CDCl3): d 16.9, 10.9; 1H NMR
(200 MHz, CDCl3): d 2.05 (m, 4H), 3.50 (m, 5H), 7.20 (m, 10H); 13C
NMR (50 MHz, CDCl3): d 26 (d, J 3.7 Hz), 27.1 (d, J 5.2 Hz), 31.3 (d,
J 2.8 Hz), 32.3 (d, J 2.9 Hz), 44.5 (d, J 2.7 Hz), 46.5 (d, J 2.7 Hz),
49.7 (d, J 19.2 Hz), 51.4 (d, J 16.3 Hz), 56.9 (d, J 10.6 Hz), 57.7 (d, J
11.6 Hz), 116.0 (d, J 3.7 Hz), 117.0 (d, J 5.2 Hz), 120.8 (d, J 3.7 Hz),
121.0 (d, J 5.2 Hz), 121.4 (d, J 3.7 Hz), 121.8 (d, J 5.2 Hz), 124.5 (d,
J 3.7 Hz), 124.7 (d, J 5.2 Hz), 129.2 (d, J 4.5 Hz), 129.3 (s), 129.7 (s),
141.4 (s), 141.6 (s), 151.2 (s), 151.9 (s); C17H19N2O2P (314.32): calcd. C 65.0,
H 6.1, N 8.9, P 9.9; found: C 65.6, H 6.2, N 9.0, P 9.8.
General procedure for the preparation of compounds 3b ± k: To a stirred
solution of the corresponding compounds (2a ± k) (2.5 mmol) in dry THF
(25 mL) under N2 was slowly added at 788C a solution of LDA (2m in
THF, 5.5 mmol). The mixture was allowed to warm to RT and was then
quenched by addition of a saturated solution of NH4Cl (20 mL). The
product was extracted with ethyl acetate (2 Â 30 mL). The combined
organic phases were dried over MgSO4, filtered, and evaporated under
reduced pressure. The residue was purified by flash chromatography on a
silica gel column.
(2S,4R,5S)-3,4-Dimethyl-2-(2-hydroxyphenyl)-5-phenyl-1,3,2-oxazaphos-
pholidine 2-oxide (3b): Purification by column chromatography (silica gel;
ethyl acetate/petroleum ether 33:67) afforded 3b as a white solid in 86%
yield. M.p. 1098C; [a]D25
4.4 (c 0.45, CH2Cl2); 31P NMR (40.5 MHz,
(2S,5S)-2-Naphthoxy-3-phenyl-1,3-diaza-2-phosphabicyclo[3.3.0]octane 2-
oxide (2g) and (2R,5S)-2-naphthoxy-3-phenyl-1,3-diaza-2-phosphabicy-
clo[3.3.0]octane 2-oxide (2h): Purification by column chromatography
(silica gel; ethyl acetate/petroleum ether 75:25) afforded an inseparable
mixture (60:40) of the two diastereomers 2g and 2h as a white solid in 76%
yield. 31P NMR (40.5 MHz, CDCl3): d 16.7 (major), 11.4 (minor); 1H
NMR (200 MHz, CDCl3): d 1.85 (m, 4H), 3.50 (m, 5H), 6.90 (m, 1H), 7.15
(m, 8H), 7.50 (m, 1H), 7.80 (m, 2H); 13C NMR (50 MHz, CDCl3): d 26.0
(d, J 4 Hz), 27.2 (d, J 5.3 Hz); 31.4 (d, J 2.6 Hz), 32.3 (s), 44.8 (d, J
2.7 Hz), 46.5 (d, J 2.8 Hz), 49.7 (d, J 18.6 Hz), 51.7 (d, J 16.4 Hz), 57.0
(d, J 10.2 Hz), 58.0 (d, J 11.5 Hz), 115.5 (d, J 3.2 Hz), 116.4 (d, J
4.5 Hz), 117.2 (d, J 4.5 Hz), 121.4 (s), 121.7 (s), 122 (s), 122.1 (s), 124.3 (s),
124.6 (s), 125.5 (s), 125.9 (s), 126.3 (s), 126.6 (s), 127.2 (s), 127.6 (s), 129.2 (s),
129.4 (s), 134.7 (s), 141.3 (s), 141.6 (s), 147.2 (s), 148 (s); C21H21N2O2P
(364.38): calcd. C 69.2, H 5.8, N 7.7, P 8.5; found C 68.9, H 5.7, N 7.9, P 8.7.
CDCl3): d 38.6; 1H NMR (200 MHz, CDCl3): d 0.97 (d, J 6.5 Hz, 3H),
2.68 (d, J 10.3 Hz, 3H), 3.90 (m, 1H), 5.76 (dd, J 6.7 Hz, J 4.4 Hz,
1H), 7.00 (m, 2H); 7.40 (m, 7H); 10.80 (s, 1H); 13C NMR (50 MHz, CDCl3):
d 14.8 (s), 28.5 (d, J 6.1 Hz), 59.4 (d, J 11.2 Hz), 83.4 (s), 109.2 (d, J
168.5 Hz), 117.9 (d, J 11.1 Hz), 119.4 (d, J 14.4 Hz), 126.1 (s, 2C), 128.4
(d, J 4.2 Hz, 2C), 131.3 (s), 131.4 (s), 135.2 (s), 135.7 (d, J 4.6 Hz), 163.4
(d, J 7.2 Hz); C16H18NO3P (303.29): calcd. C 63.4, H 6.0, N 4.6, P 10.2;
found C 63.5, H 6.1, N 4.7, P 10.1.
(2S,4S)-4-Isopropyl-2-(2-hydroxyphenyl)-3-methyl-1,3,2-oxazaphospholi-
dine 2-oxide (3c): Purification by column chromatography (silica gel; ethyl
acetate/petroleum ether 25:75) afforded 3c as a pale yellow solid in 89%
yield. M.p. 888C; [a]D25 62.0 (c 0.55, CH2Cl2); 31P NMR (40.5 MHz,
CDCl3): d 40.8; 1H NMR (200 MHz, CDCl3): d 1.01 (d, J 7.0 Hz, 3H),
1.07 (d, J 6.8 Hz, 3H), 2.18 (m, 1H), 2.56 (d, J 9.9 Hz, 3H), 3.58 (m,
1H), 4.35 (m, 2H), 6.92 (m, 2H), 7.17 (m, 1H) ), 7.46 (m, 1H), 10.8 (s, 1H);
13C NMR (50 MHz, CDCl3): d 14.5 (s), 18.2 (s), 27.6 (d, J 3.7 Hz), 28.7
(d, J 8.7 Hz), 64.3 (d, J 11.5 Hz), 66.8 (s), 109.4 (d, J 164.5 Hz), 117.9
(d, J 11.2 Hz), 119.3 (d, J 14.5 Hz), 130.8 (d, J 8.7 Hz), 135.0 (s), 163.2
(d, J 6.7 Hz); C12H18NO3P (255.25): calcd. C 56.5, H 7.1, N 5.5, P 12.1;
found C 56.7, H 7.2, N 5.6, P 12.3.
(1S,6S)-7,9-Dimethyl-8-phenoxy-7,9-diaza-8-phosphabicyclo[4.3.0]nonane
8-oxide (2i): Purification by column chromatography (silica gel; ethyl
acetate/petroleum ether 80:20) afforded 2i as a pale yellow syrup in 85%
yield. [a]2D5
56.0 (c 0.925, CH2Cl2); 31P NMR (40.5 MHz, CDCl3): d
23.8; 1H NMR (200 MHz, CDCl3): d 1.25 (m, 4H), 1.80 (m, 2H), 2.05 (m,
2H), 2.60 (m, 2H), 2.60 (d, J 2.0 Hz, 3H), 2.65 (d, J 2.1 Hz, 3H), 7.25
(m, 5H); 13C NMR (50 MHz, CDCl3): d 23.8 (s, 2C), 27.6 (s), 27.8 (s), 28.1
(d, J 10.6 Hz), 29.7 (d, J 2.4 Hz), 62.5 (d, J 10.0 Hz), 64.5 (d, J
9.9 Hz), 120.7 (d, J 3.9 Hz, 2C), 124.0 (s), 129.2 (s, 2C), 151.4 (d, J
9.0 Hz); C14H21N2O2P (280.30): calcd. C 60.0, H 7.5, N 10.0, P 11.0; found C
60.6, H 7.7, N 9.9, P 11.2.
(2R,4S)-4-Isopropyl-2-(2-hydroxyphenyl)-3-methyl-1,3,2-oxazaphospholi-
dine 2-oxide (3d): Purification by column chromatography (silica gel; ethyl
acetate/petroleum ether 25:75) afforded 3d as a pale yellow solid in 92%
yield. M.p. 1068C; [a]D25
15.0 (c 0.6, CH2Cl2); 31P NMR (40.5 MHz,
CDCl3): d 44.0; 1H NMR (200 MHz, CDCl3): d 0.98 (d, J 7.0 Hz, 3H),
1.00 (d, J 6.9 Hz, 3H), 2.13 (m, 1H), 2.61 (d, J 11.0 Hz, 3H), 3.55 (m,
1H), 4.15 (m, 1H), 4.45 (m, 1H), 6.90 (m, 2H), 7.30 (m, 2H), 10.8 (s, 1H);
13C NMR (50 MHz, CDCl3): d 15.1 (s), 18.1 (s), 28.1 (d, J 7.4 Hz), 29.4
(d, J 5.7 Hz), 62.7 (d, J 9.9 Hz), 67.9 (d, J 2.2 Hz), 109.1 (d, J
174.5 Hz), 117.9 (d, J 12.2 Hz), 119.3 (d, J 14.2 Hz), 132.1 (d, J
7.2 Hz), 135.3 (d, J 2.7 Hz), 163.7 (d, J 4.4 Hz); C12H18NO3P (255.25):
calcd. C 56.5, H 7.1, N 5.5, P 12.1; found C 56.9, H 7.1, N 5.4, P 12.2.
(4S,5S)-1,3-Dimethyl-4,5-diphenyl-2-phenoxy-1,3,2-diazaphospholidine 2-
oxide (2j): Purification by column chromatography (silica gel; ethyl
acetate/petroleum ether 80:20) afforded 2j as a pale yellow syrup in 80%
yield. M.p. 1088C; [a]D25 22.5 (c 1, CH2Cl2); 31P NMR (40.5 MHz,
CDCl3): d 20.3; 1H NMR (200 MHz, CDCl3): d 2.56 (d, J 2.5 Hz, 3H),
2.61 (d, J 6 Hz, 3H), 3.97 (dd, J 21.3 Hz, J 8.5 Hz, 2H), 6.90 (m, 2H),
7.30 (m, 13H); 13C NMR (50 MHz, CDCl3): d 29.8 (d, J 3.8 Hz), 30.8 (d,
J 2.4 Hz), 70.3 (d, J 11.7 Hz), 71.5 (d, J 12.5 Hz), 121.0 (s), 121.1 (s),
124.5 (s), 127.6 (s, 2C), 127.9 (s), 128.2 (s), 128.5 (d, J 6.7 Hz, 2C),129.0 (s,
2C), 129.7 (s), 137.0 (d, J 10.1 Hz), 137.9 (d, J 7.3 Hz), 152.4 (d, J
8.6 Hz); C22H23N2O2P (378.41): calcd. C 69.8, H 6.1, N 7.4, P 8.2; found C
70.2, H 6.0, N 7.2, P 8.3.
(2S,5S)-2-(2-hydroxyphenyl)-3-phenyl-1,3-diaza-2-phosphabicyclo[3.3.0]-
octane 2-oxide (3e) and (2R,5S)-2-(2-hydroxyphenyl)-3-phenyl-1,3-diaza-
2-phosphabicyclo[3.3.0]octane 2-oxide (3 f): Purification by column chro-
matography (silica gel; ethyl acetate/petroleum ether 50:50) afforded 3e as
a white solid in 47% yield and 3 f as a white solid in 44% yield.
(1R,7R)-9,9-Dimethyl-4-phenoxy-3,5,8,10-tetraoxa-4-phosphabicyclo-
[5.3.0]decane 4-oxide (2k): Purification by column chromatography (silica
gel; ethyl acetate/petroleum ether 50:50) afforded 2k as a colorless syrup in
25% yield. [a]2D5 50.9 (c 1.1, CH2Cl2); 31P NMR (40.5 MHz, CDCl3):
d 8.1; 1H NMR (200 MHz, CDCl3): d 1.47 (s, 6H), 4.20 (m, 2H), 4. 50
(m, 4H), 7.30 (m, 5H); 13C NMR (50 MHz, CDCl3): d 26.6 (s), 26.7 (s),
66.3 (d, J 5.5 Hz), 67.1 (d, J 5.8 Hz), 77.6 (s), 78.0 (s), 111.4 (s), 119.9 (d,
3e: M.p. 1588C; [a]D25 51.4 (c 0.7, CH2Cl2); 31P NMR (40.5 MHz,
1
CDCl3): d 33.2; H NMR (200 MHz, CDCl3): d 1.95 (m, 4H), 2.97 (m,
1H), 3.57 (m, 1H), 3.76 (m, 1H), 3.99 (m, 2H), 6.78 (m, 1H), 6.97 (m, 4H),
7.19 (m, 4H), 11.15 (s, 1H); 13C NMR (50 MHz, CDCl3): d 26.7 (s), 32.3
(s), 44.5 (s), 49.7 (d, J 14.6 Hz), 60.0 (d, J 5.9 Hz), 112.8 (d, J
164.3 Hz), 116.5 (d, J 5.8 Hz, 2C), 117.6 (d, J 11.7 Hz), 119.5 (d, J
13.2 Hz), 121.9 (s), 129.3 (s, 2C), 131.4 (d, J 7.4 Hz), 134.3 (d, J 3.0 Hz),
Chem. Eur. J. 1998, 4, No. 6
ꢁ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 1998
0947-6539/98/0406-1065 $ 17.50+.25/0
1065